Twist Bioscience Corporation

NasdaqGS:TWST Rapport sur les actions

Capitalisation boursière : US$2.5b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Twist Bioscience Gestion

Gestion contrôle des critères 3/4

Le PDG Twist Bioscience's est Emily Leproust, nommé en Apr2013, a un mandat de 11.33 ans. La rémunération annuelle totale est $ 8.00M, composée du salaire de 8.6% et des bonus 91.4%, y compris les actions et options de la société. détient directement 0.39% des actions de la société, d'une valeur de $ 10.03M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.2 ans et 7.8 ans.

Informations clés

Emily Leproust

Directeur général

US$8.0m

Rémunération totale

Pourcentage du salaire du PDG8.6%
Durée du mandat du directeur général11.3yrs
Propriété du PDG0.4%
Durée moyenne d'occupation des postes de direction3.2yrs
Durée moyenne du mandat des membres du conseil d'administration7.8yrs

Mises à jour récentes de la gestion

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Recent updates

Investors Aren't Buying Twist Bioscience Corporation's (NASDAQ:TWST) Revenues

Aug 20
Investors Aren't Buying Twist Bioscience Corporation's (NASDAQ:TWST) Revenues

Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)

Aug 04

Twist Bioscience: Growing Customer Base And Technology Platform Make Me Like This Stock

Jul 26

We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth

Jun 10
We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth

Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth

May 04
Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth

Twist Bioscience: NGS Is Taking Off

May 03

Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Feb 27
Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Twist Bioscience: Strong Performance In A Soft Market

Feb 07

Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

Jan 31
Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet

We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Jan 22
We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate

Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Dec 18
Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%

Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

Oct 05
Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans

We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Jul 07
We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth

Twist Biosciences collaborates with Enzolytics on monoclonal antibodies for viruses

Sep 16

Twist Bioscience: DNA Synthesis Leader Appealing 'Picks And Shovels' Play

Sep 02

Twist Bioscience: DNA Synthesis Leader Is Just Getting Started

Aug 08

Analyse de la rémunération des PDG

Comment la rémunération de Emily Leproust a-t-elle évolué par rapport aux bénéfices de Twist Bioscience?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

-US$220m

Mar 31 2024n/an/a

-US$192m

Dec 31 2023n/an/a

-US$206m

Sep 30 2023US$8mUS$685k

-US$205m

Jun 30 2023n/an/a

-US$209m

Mar 31 2023n/an/a

-US$213m

Dec 31 2022n/an/a

-US$214m

Sep 30 2022US$6mUS$665k

-US$218m

Jun 30 2022n/an/a

-US$208m

Mar 31 2022n/an/a

-US$188m

Dec 31 2021n/an/a

-US$165m

Sep 30 2021US$1mUS$590k

-US$152m

Jun 30 2021n/an/a

-US$135m

Mar 31 2021n/an/a

-US$123m

Dec 31 2020n/an/a

-US$117m

Sep 30 2020US$7mUS$519k

-US$140m

Jun 30 2020n/an/a

-US$147m

Mar 31 2020n/an/a

-US$147m

Dec 31 2019n/an/a

-US$141m

Sep 30 2019US$8mUS$477k

-US$108m

Jun 30 2019n/an/a

-US$96m

Mar 31 2019n/an/a

-US$86m

Dec 31 2018n/an/a

-US$77m

Sep 30 2018US$525kUS$362k

-US$71m

Jun 30 2018n/an/a

-US$68m

Sep 30 2017US$2mUS$340k

-US$59m

Rémunération vs marché: La rémunération totale de Emily ($USD 8.00M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 6.76M ).

Rémunération et revenus: La rémunération de Emily a augmenté alors que l'entreprise n'est pas rentable.


PDG

Emily Leproust (51 yo)

11.3yrs

Titularisation

US$7,998,637

Compensation

Dr. Emily Marine Leproust, Ph.D. serves as Independent Director at CM Life Sciences, Inc. since September 2, 2020. She serves as an Independent Director at GeneDx Holdings Corp. (formerly known as Sema4 Ho...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Emily Leproust
Co-Founder11.3yrsUS$8.00m0.39%
$ 9.7m
Patrick Finn
President & COO1.8yrsUS$5.23m0.085%
$ 2.1m
Paula Green
Senior Vice President of Human Resources8.4yrsUS$2.49m0.037%
$ 920.1k
William Banyai
Senior VP of Advanced Development4.6yrsUS$2.82m0.44%
$ 11.1m
Adam Laponis
Chief Financial Officerless than a yearpas de données0.0029%
$ 74.2k
Robert Werner
VP & Chief Accounting Officer1.3yrspas de données0.0099%
$ 248.6k
Siyuan Chen
Chief Technology Officer3.5yrspas de donnéespas de données
Aaron Sato
Chief Scientific Officer3.5yrspas de donnéespas de données
Chet Gandhi
Chief Information Officer1.2yrspas de donnéespas de données
Dennis Cho
Senior VP2.9yrsUS$1.96m0.047%
$ 1.2m
Angela Bitting
Chief ESG Officer & Senior VP of Corporate Affairs3.5yrspas de donnéespas de données
Mark Buck
Senior Vice President of Operationsless than a yearpas de donnéespas de données

3.2yrs

Durée moyenne de l'emploi

52yo

Âge moyen

Gestion expérimentée: L'équipe de direction de TWST est considérée comme expérimentée (ancienneté moyenne 3.2 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Emily Leproust
Co-Founder11.3yrsUS$8.00m0.39%
$ 9.7m
William Banyai
Senior VP of Advanced Development11.3yrsUS$2.82m0.44%
$ 11.1m
Keith Crandell
Independent Director10.8yrsUS$272.49k0.16%
$ 4.0m
Robert Chess
Lead Independent Director10.1yrsUS$303.98k0.11%
$ 2.8m
Nelson Chan
Independent Director5.3yrsUS$284.99k0.030%
$ 766.7k
Robert Ragusa
Independent Director7.8yrsUS$271.34k0.023%
$ 583.7k
Jan Johannessen
Independent Director5.8yrsUS$284.99k0.020%
$ 498.5k
Melissa Starovasnik
Independent Director3yrsUS$276.61k0.019%
$ 467.1k
Xiaoying Mai
Independent Director6.1yrsUS$269.99k0.043%
$ 1.1m

7.8yrs

Durée moyenne de l'emploi

64yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de TWST sont considérés comme expérimentés (ancienneté moyenne 7.8 ans).